Form 4: Broadwood Partners Boosts STAAR Surgical Stake

Broadwood Partners, a 10% owner and director, acquired additional common stock in STAAR Surgical Co. on January 9, 2026.

Summary

• Broadwood Partners, L.P., identified as a 10% owner and director of STAAR Surgical Co. [STAA], acquired 27,485 shares of common stock.
• The transaction occurred on January 9, 2026, with shares purchased at a weighted average price of $22.0534, ranging from $21.965 to $22.09.
• Following this acquisition, Broadwood Partners, L.P. indirectly beneficially owns 15,453,629 shares of STAAR Surgical Co.
• Neal C. Bradsher, President of Broadwood Capital, Inc. (General Partner of Broadwood Partners), directly owns an additional 25,900 shares.
• Broadwood Capital, Inc. and Neal C. Bradsher are also identified as 10% owners and directors of STAAR Surgical Co.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant insider (10% owner and director) increasing their stake in the company, which typically signals confidence in future performance and valuation.

Positives

• A significant insider, Broadwood Partners, L.P. (a 10% owner and director), increased its stake in STAAR Surgical Co., signaling strong confidence in the company's future performance and valuation.
• The purchase of 27,485 shares at a weighted average price of $22.0534 indicates a specific valuation point at which the insider believes the stock is attractive.

Related Party Transactions

• Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher, all identified as 10% owners and directors of STAAR Surgical Co., engaged in the purchase of company common stock.

Stakeholder Impact

• Shareholders may view the insider buying as a positive signal, potentially increasing confidence in the company's stock and future prospects.
• The transaction demonstrates continued commitment and belief in the company's value by a significant institutional investor and its principals.

Key Dates

Recommendation

The acquisition of additional common stock by a 10% owner and director, Broadwood Partners, L.P., signals strong insider confidence in STAAR Surgical Co.'s future prospects. Such a significant purchase by a well-informed party often precedes positive developments or indicates a belief that the stock is undervalued, making it a compelling 'buy' signal for investors.

Keywords

STAAR Surgical, STAA, Broadwood Partners, Insider Buying, Form 4, Beneficial Ownership, Equity Acquisition, Investment, Ophthalmology, Medical Devices